Evidence map›Paper›PMID 40748553›Full record

ReviewJapanese journal of ophthalmology2025

Advancements in robotic surgery for vitreoretinal diseases: current trends and the future.

Shintaro Nakao, Kotaro Tadano, Koh-Hei Sonoda

Abstract readReview
In one paragraph

Review in Japanese journal of ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Shintaro NakaoDepartment of Ophthalmology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Kotaro TadanoInstitute of Innovation Research, Institute of Science Tokyo, Yokohama, Japan.
Koh-Hei SonodaDepartment of Ophthalmology, Graduate School of Medical Science, Kyushu University, Kyushu University, 3-1-1 Maidashi, Higashi-Ku, Fukuoka, 812-8582, Japan. k.sonoda.a74@m.kyushu-u.ac.jp.ORCID http://orcid.org/0000-0002-9819-5509

Funding

AMED JP121he1702002
6 · The paper itself

Abstract

Medical robotics, such as the da Vinci Surgical System, Hinotori, and Saroa, has been rapidly expanding in the field of general surgery in recent years. Because of the need for high precision in vitreoretinal surgery, general surgery robots are not applicable; therefore, a variety of robots specifically designed for vitreoretinal surgery have been developed around the world. These robotic systems can be broadly categorized into operation systems, operation assistance systems, and observation systems. The purpose of the operation robots is mainly internal limiting membrane peeling and retinal vascular cannulation. The PRECEYES Surgical System was already approved in the European Union in 2019 on the basis of positive clinical results. The aim of operation assistance robots, such as iARMs, is to suppress tremors. Meanwhile, we have developed an observation robot, an intraocular endoscope-holding robot (OQrimo), which was approved as a medical device in Japan in 2023. This robot allows surgeons to perform intraocular manipulations using both hands during vitreoretinal surgery for proliferative diabetic retinopathy and other intractable retinal diseases and may also make it easier to manipulate the anterior tissues around the ciliary body. In the future, by being combined with artificial intelligence in vitreoretinal clinics, robotic surgery will be applied to preoperative, intraoperative, and postoperative surgical procedure decisions, programs, and education.

Indexed as

Retinal DiseasesRobotic Surgical ProceduresVitreoretinal SurgeryHumansObservation robotOperation assistance robotRoboticsVitreoretinal surgery

Identifiers

PMID40748553
PMCPMC12339589

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.